HEALTH X PLATFORM LIMITED

BSE: HEALTHX533259ISIN INE019J01013

Healthcare
Healthcare Service Provider

Share price

₹271.20-9.50 (-3.38%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹375.00
52W low: ₹252.50
Off 52W high: -27.68%
1M return: -0.13%
3M return: -11.72%
6M return: -4.84%
1Y return: -8.73%
20D avg volume: 396
50 DMA: ₹289.59
200 DMA: ₹294.96

Key ratios Consolidated

Market cap: ₹862.70 Cr
Current price: ₹271.20
52W high / low: ₹375.00 / ₹252.50
Face value: ₹10.00
P/E: -33.11
P/B: 1.35
EPS (TTM): ₹-8.19
Book value / share: ₹201.47
ROE: —
ROCE: —
Operating margin: —
Net margin: —
Debt / equity: 0.03
Net debt: ₹-8.10 Cr
Interest cover: -2.03
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	446.85	373.78	345.74	301.32	298.43	285.84	281.29	273.53	270.29	306.67	374.50	358.49
	12.83	13.76	13.62	5.51	25.38	21.63	11.83	22.29	27.75	18.46	20.13	9.71
	459.68	387.54	359.35	306.83	323.81	307.47	269.46	295.82	298.04	325.13	394.63	368.20
	457.70	401.40	358.44	325.31	293.62	312.38	306.47	279.77	274.40	320.12	373.63	357.56
	0.17	0.10	0.15	0.30	0.25	0.31	0.35	0.46	0.62	0.43	0.32	0.73
	447.98	373.56	325.83	289.28	260.22	268.65	267.56	234.79	244.77	250.99	319.49	325.19
	27.68	25.04	21.72	19.87	17.34	16.31	11.23	11.63	10.62	11.94	12.32	12.91
	0.59	0.49	0.17	0.04	0.09	0.01	0.05	0.06	0.10	0.28	0.24	0.24
	1.89	1.94	2.17	1.33	1.17	1.34	1.43	1.45	1.61	2.53	2.31	2.20
	21.45	23.34	19.17	19.07	17.43	29.43	30.72	20.28	19.35	23.74	23.02	21.93
	1.98	-13.87	0.92	-18.47	30.19	-4.92	-37.01	16.05	23.64	5.01	21.00	10.64
	0.00	-0.96	0.00	-0.17	0.00	0.28	-2.23	-189.68	1.00	0.00	0.00	0.00
	1.98	-14.83	0.92	-18.64	30.19	-4.63	-39.24	-173.63	24.64	5.01	21.00	10.64
	-0.01	-1.86	0.55	-3.20	3.59	-22.21	—	—	—	—	—	—
	1.99	-12.97	0.37	-15.44	26.59	17.57	-37.79	-154.79	40.97	21.57	-3.23	-12.20
	0.80	-3.51	0.35	-3.99	7.52	4.30	-8.47	-34.40	9.79	5.17	-0.23	-2.55
Key metrics
	—	—	—	—	—	—	-37.76	-172.12	26.35	7.82	23.55	13.08
	—	—	—	—	—	—	-13.40%	-62.90%	9.70%	2.50%	6.30%	3.60%
	0.40%	-3.50%	0.10%	-5.10%	8.90%	6.10%	-13.40%	-56.60%	15.20%	7.00%	-0.90%	-3.40%
	49.70%	30.80%	22.90%	10.20%	10.40%	-6.80%	-24.90%	-23.70%	—	—	—	—
	-92.50%	-173.80%	101.00%	90.00%	-35.10%	-18.50%	-1,070.00%	-1,168.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	1,468	1,319	1,111	1,376	1,040	631.43
	45.72	58.27	59.84	60.41	23.64	11.63
	1,513	1,378	1,171	1,436	1,063	643.06
	1,543	1,379	1,173	1,380	1,093	685.88
	0.72	0.80	1.74	1.95	3.04	3.05
	1,437	1,249	1,016	1,168	1,028	616.73
	94.31	83.97	49.79	49.02	45.34	43.94
	1.29	0.78	0.22	1.01	0.87	1.64
	7.33	6.60	5.83	9.14	8.20	4.16
	83.03	79.02	99.78	88.50	78.04	53.68
	-29.44	-1.23	-2.23	55.68	-29.39	-42.81
	-1.13	-1.13	-190.63	0.00	-7.96	1,157
	-30.57	-2.36	-192.86	55.68	-37.35	1,115
	-4.52	-0.91	-70.12	—	—	—
	-26.05	-1.45	-133.54	5.85	-99.47	978.37
	-6.35	0.37	-28.66	2.79	-22.70	222.73
Key metrics
	—	—	—	65.83	-28.28	1,120
	—	—	—	4.80%	-2.70%	177.40%
	-1.77%	-0.10%	-12.00%	0.40%	-9.60%	154.90%
	28.85%	18.80%	-19.20%	32.30%	64.70%	—
	—	98.90%	-2,382.70%	105.90%	-110.20%	—
	—	-88.76	-27.67	—	—	—
	—	50.92	0.13	—	—	—
	—	0.03	0.00	—	—	—
	—	-8.10	-12.42	—	—	—
Balance sheet
	—	935.77	974.37	—	—	—
	—	30.19	12.42	—	—	—
	—	7.66	9.98	—	—	—
	—	144.65	110.29	—	—	—
	—	78.17	63.37	—	—	—
	—	22.09	0.00	—	—	—
	—	765.27	864.53	—	—	—
Cash flow
	—	-73.83	-17.31	—	—	—
	—	171.19	-1.13	—	—	—
	—	-79.59	-0.44	—	—	—
	—	14.93	10.36	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	0.08	0.09	0.10	0.10	0.10	0.10	0.11	0.11	0.08	0.00	0.00	0.00
	0.01	0.10	0.01	0.01	0.26	0.20	0.20	0.19	0.22	0.32	0.29	0.28
	0.09	0.19	0.11	0.11	0.35	0.30	0.30	0.30	0.30	0.32	0.29	0.28
	0.61	0.34	0.52	0.39	0.46	0.37	0.41	0.62	0.52	0.39	0.53	0.49
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.08	0.08	0.08	0.07	0.07	0.09	0.09	0.16	0.12	0.14	0.12	0.14
	0.00	0.00	0.00	0.00	0.06	0.00	0.00	0.00	0.00	0.01	0.00	0.00
	0.02	0.02	0.03	0.02	0.02	0.03	0.02	0.03	0.02	0.03	0.03	0.03
	0.50	0.24	0.41	0.29	0.31	0.25	0.29	0.43	0.37	0.21	0.38	0.33
	-0.51	-0.15	-0.41	-0.28	-0.11	-0.07	-0.10	-0.32	-0.22	-0.07	-0.24	-0.21
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	-0.51	-0.15	-0.41	-0.28	-0.11	-0.07	-0.10	-0.32	-0.22	-0.07	-0.24	-0.21
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	-0.51	-0.15	-0.41	-0.28	-0.11	-0.07	-0.10	-0.32	-0.22	-0.07	-0.24	-0.21
	-0.16	-0.05	-0.13	-0.09	-0.03	-0.02	-0.03	-0.10	-0.07	-0.02	-0.08	-0.06
Key metrics
	—	—	—	—	—	—	-0.08	-0.29	-0.20	-0.03	-0.21	-0.18
	—	—	—	—	—	—	-72.70%	-263.60%	-250.00%	—	—	—
	-637.50%	-166.70%	-410.00%	-280.00%	-110.00%	-70.00%	-90.90%	-290.90%	-275.00%	—	—	—
	-20.00%	-10.00%	-9.10%	-9.10%	25.00%	—	—	—	—	—	—	—
	-363.60%	-114.30%	-310.00%	12.50%	50.00%	0.00%	58.30%	-52.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	0.37	0.38	0.40	0.00	0.00	0.00
	0.13	0.38	0.80	1.18	2.25	0.92
	0.50	0.76	1.20	1.18	2.25	0.92
	1.86	1.71	1.92	2.07	1.60	1.25
	0.00	0.00	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	0.00	0.00
	0.31	0.30	0.47	0.51	0.43	0.35
	0.00	0.06	0.01	0.02	0.01	0.01
	0.09	0.10	0.10	0.10	0.16	0.18
	1.44	1.26	1.34	1.44	1.00	0.71
	-1.35	-0.95	-0.71	-0.89	0.65	-0.34
	0.00	0.00	0.00	0.00	0.00	0.00
	-1.35	-0.95	-0.71	-0.89	0.65	-0.34
	0.00	0.00	0.00	—	—	—
	-1.35	-0.95	-0.71	-0.89	0.65	-0.39
	-0.43	-0.30	-0.22	-0.28	0.20	-0.12
Key metrics
	—	—	—	-0.77	0.82	-0.15
	-364.86%	-250.00%	-177.50%	—	—	—
	-11.90%	-5.00%	—	—	—	—
	—	-33.80%	20.20%	-236.90%	266.70%	—
	—	0.04	-5.52	—	—	—
	—	-0.04	7.76	—	—	—
	—	0.00	0.00	—	—	—
	—	-0.05	-0.03	—	—	—
Balance sheet
	—	271.02	272.16	—	—	—
	—	0.05	0.03	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	1.76	1.94	—	—	—
	—	0.00	0.00	—	—	—
	—	270.86	271.81	—	—	—
Cash flow
	—	0.04	-5.51	—	—	—
	—	-0.01	5.45	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.01	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: -30.36%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -11.90%
Profit YoY (TTM): -125.00%

Consolidated

Sales CAGR 3Y: +8.26%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +28.85%
Profit YoY (TTM): +82.45%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 74.06%

Quarter	September 2026	June 2026
Promoter %	74.06%	74.06%

Holder	Type	Holding	Previous	Change
Banwari Lal Mittal	Promoter	33.92%	33.92%	0.00%
Topview Enclaves LLP	Promoter Group	24.76%	24.76%	0.00%
Luv Kush Projects Limited	Promoter Group	11.96%	11.96%	0.00%
Ravi Kant Sharma	Promoter	2.35%	2.35%	0.00%
Lekh Raj Juneja	Public	1.89%	1.89%	0.00%
Magnum Health And Safety Pvt Ltd	Public	1.33%	1.44%	-0.11%
Sanjay Agarwal, Rahul Kumar Agrawal and Pratap Singh as Trustees of Microsec Vision Employees Trust	Public	1.28%	1.28%	0.00%
Airavat Capital Trust - Airavat Capital Trust II	Public	1.23%	1.23%	0.00%
Legends Global Opportunities (Singapore) Pte. Ltd.	Public	1.18%	1.15%	+0.03%
Bharati Sharma	Promoter Group	1.02%	1.02%	0.00%
Abha Mittal	Promoter Group	0.05%	0.05%	0.00%
B L Mittal HUF (Karta Banwari Lal Mittal)	Promoter Group	0.00%	0.00%	0.00%
Club Kautilya Fintech Private Limited	Promoter Group	0.00%	0.00%	0.00%
Giridhari Lal Mishra	Promoter Group	0.00%	0.00%	0.00%
Mohit Sharma	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

Please find the Certificate under Reg 74(5) of the SEBI (Depositories and Participants) Reg, 2018 for the quarter ended 30th September, 20269 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure of Voting Results of the 37th AGM of the Company held on Monday, 28th September, 202629 Sep 2026 · AGM/EGM / AGM
Consolidated Scrutinizer''s Report dated September 29, 2026.29 Sep 2026 · AGM/EGM / AGM
Brief Proceedings of 37th Annual General Meeting of the Members of the Company held on Monday, 28th September, 2026.28 Sep 2026 · AGM/EGM / AGM
Intimation of closure of Trading Window25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication regarding Notice of 37th Annual General Meeting and e-voting information.5 Sep 2026 · Company Update / Newspaper Publication
Please find attached the disclosure under Reg 30 and Reg 36(1)(b) of SEBI (LODR) Reg, 20154 Sep 2026 · Company Update / General
Please find attached the BRSR Report for FY 2025-26.4 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report of the Company for the FY 2025-264 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please find attached the Notice of the 37th Annual General Meeting of the Company4 Sep 2026 · AGM/EGM / AGM
Newspaper Publication for Information to the shareholders regarding the 37th AGM of the Company to be held on Monday, September 28, 20261 Sep 2026 · Company Update / Newspaper Publication
Please find attached the intimation regarding the 37th AGM of the Company.31 Aug 2026 · AGM/EGM / AGM
Please find attached the intimation alongwith registration link.25 Aug 2026 · Company Update / Analyst / Investor Meet
Please find attached the disclosure.17 Aug 2026 · Company Update / Earnings Call Transcript
Disclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q1 FY2711 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended 30th June, 20268 Aug 2026 · Company Update / Newspaper Publication
Please find attached the Investor Presentation of the Company7 Aug 2026 · Company Update / Investor Presentation
Please find attached the disclosure7 Aug 2026 · Company Update / Change in Management
Please find attached the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30.06.20267 Aug 2026 · Result / Financial Results
Please find attached the Outcome of Board meeting held on 7th August, 20267 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule of the Earnings Conference Call for Q1 of FY2026-27 and registration Link thereof5 Aug 2026 · Company Update / Analyst / Investor Meet
Please find the disclosure attached herewith.3 Aug 2026 · Company Update / General
Health X Platform Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Unaudited Standalone ....30 Jul 2026 · Board Meeting / Board Meeting
Please find the certificate under Reg 74(5) of SEBI (Depositories and Participants) Reg, 2018 for the quarter ended 30th June, 20269 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading Window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Disclosure under Reg 30 of SEBI (LODR) - Transcript of Group Conference Call19 Jun 2026 · Company Update / Earnings Call Transcript
Disclosure under Listing Regulations - Submission of Audio recording of the Group Conference call for Q4 FY2613 Jun 2026 · Company Update / Analyst / Investor Meet
Please find attached the Investor Presentation.10 Jun 2026 · Company Update / Investor Presentation
Please find attached the disclosure10 Jun 2026 · Company Update / Scheme of Arrangement
Please find the disclosure attached herewith.10 Jun 2026 · Others / Outcome without intimation
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ravi Kant Sharma & PACs6 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Please find attached the disclosure.5 Jun 2026 · Company Update / General
Intimation of Schedule of Investors / Analysts Meeting under the SEBI LODR Reg, 2015 and the registration Link2 Jun 2026 · Company Update / Analyst / Investor Meet
Please find the Intimation for change of website of the Company2 Jun 2026 · Company Update / General
Please find attached herewith the Investor Presentation.1 Jun 2026 · Company Update / Investor Presentation
Newspaper publication of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 20261 Jun 2026 · Company Update / Newspaper Publication
Intimation of Re-appointment of Internal Auditors of the Company30 May 2026 · Company Update / Change in Management
Audited Financial Results for the quarter and financial year ended March 31, 202630 May 2026 · Result / Financial Results
Outcome of Board Meeting for the quarter and year ended March 31, 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Annual Secretarial Compliance Report for the financial year ended 31st March, 202628 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance

Board meetings

7 Aug 2026 Board Meeting - Financial Results